Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele
about
The influence of UGT polymorphisms as biomarkers in solid organ transplantationPharmacogenomics: personalizing pediatric heart transplantationPersonalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicineAssociations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patientsImpact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays.A perspective on efflux transport proteins in the liverThe influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.Pharmacogenetics in kidney transplantation: recent updates and potential clinical applications.Genes and beans: pharmacogenomics of renal transplant.Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.PharmGKB summary: mycophenolic acid pathway.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.Pharmacogenetics and immunosuppressive drugs.Genetics and nonmelanoma skin cancer in kidney transplant recipients.Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis.SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.
P2860
Q27009825-E31F11FB-4F92-46CF-995D-31320B98E50BQ28081200-73606071-DA01-486E-A9F9-4578F6D623F1Q28082746-7312AF81-E1E7-44DB-800C-C6166AF8EB05Q35578549-557E4E81-9919-4555-A7E0-55AA5FDE0492Q36183911-11BD3A64-937B-413A-B330-32A3A1E10E59Q37026396-BE7E7CB5-5F41-421D-AE74-82DF4586211DQ37050337-0285A6CE-2225-4E27-B3D1-4AB207FF3687Q37857285-DA7CC3A6-8A9A-489E-B2A3-3CA352BF1398Q38063426-16500BC3-3DF4-46CB-B36D-F838F50331B8Q38104742-A72A78B5-6305-48D7-A58D-F328E23B89E1Q38120290-D278DF31-1E6D-4E23-8731-BDB3A0BCDDA4Q38162034-28D6F7E6-292C-4BF4-AA91-7C3C7ABA44DDQ38208983-6166B38D-BBB6-48B4-B58B-50F2DC85CE4FQ38253383-D0028DB8-6E2C-4359-9596-FD383C869EF9Q38258677-7554EA07-D486-4A9A-89FB-BD7D09D985ECQ38330222-1C82BFA6-8EEE-44E2-8E5A-4D1ECB74DA21Q39338374-DE987015-F568-40E7-B0B7-C4B78BE2A57CQ39622403-60ACD401-1E30-4CD6-8996-35F0A608123F
P2860
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@ast
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@en
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@nl
type
label
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@ast
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@en
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@nl
prefLabel
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@ast
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@en
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@nl
P2093
P2860
P1476
Risk of diarrhoea in a long-te ...... of the UGT1A8 2 variant allele
@en
P2093
Annick Rousseau
Eliza Munteanu
Jean-Philippe Rerolle
Marie Essig
Mireille Drouet
Nicolas Picard
Pierre Marquet
P2860
P304
P356
10.1111/J.1365-2125.2010.03625.X
P407
P577
2010-06-01T00:00:00Z